Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000155036 | SCV000204720 | likely benign | not specified | 2014-08-07 | criteria provided, single submitter | clinical testing | Pro411Ser in exon 9 of CCDC50: This variant is not expected to have clinical sig nificance due to a lack of conservation across species, including mammals. Of no te, squirrel, dog, and star-nosed mole have a serine (Ser) at this position. In addition, computational prediction tools do not suggest a high likelihood of imp act to the protein. This variant has also been identified in 1/8598 of European American chromosomes by the NHLBI Exome Sequencing Project (http://evs.gs.washin gton.edu/EVS/; dbSNP rs138707536). |
Gene |
RCV001567552 | SCV001791260 | uncertain significance | not provided | 2023-01-10 | criteria provided, single submitter | clinical testing | Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV000155036 | SCV005547776 | uncertain significance | not specified | 2024-10-12 | criteria provided, single submitter | clinical testing | The c.1231C>T (p.P411S) alteration is located in exon 9 (coding exon 9) of the CCDC50 gene. This alteration results from a C to T substitution at nucleotide position 1231, causing the proline (P) at amino acid position 411 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |